But now, Abbott’s FreeStyle Libre 2 and 3 have received the first and only FDA clearance that allows patients to keep their ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Abbott announced today that the FDA said users can wear the FreeStyle Libre 2 and 3 CGMs during common imaging procedures.

Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...

A major development towards the goal of patient and provider choice, the cloud-to-cloud integration will provide an automatic ...

The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

This multi-device solution supports Abbott’s FreeStyle Libre portfolio within Epic and Oracle Health EHR systems, marking a significant leap forward in how healthcare providers access and utilize ...

IRVINE, CA / ACCESSWIRE / October 30, 2024 / Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes ...

FreeStyle Libre continues to gain market share and driving the diabetes sales growth for Abbott. Abbott maintains its total 2024 revenue guidance of 9.5% to 10% growth on an organic basis.

Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...

Two of the most commonly used alternative-site glucose monitors are the FreeStyle Flash (Abbott Diabetes Care, Alameda, CA) and the One Touch Ultra (LifeScan, Milpitas, CA). To date, no direct ...

Oct 16 (Reuters) - Abbott Laboratories (ABT.N), opens new tab slightly lifted its annual profit forecast on Wednesday, after beating Wall Street estimates for quarterly earnings on strong demand ...